. . . and political truth memes.
This gives new meaning to the expression “narrow escape”:
H/t Auntie Lulu
Better than Drudge Report. Check out Whatfinger News, the Internet’s conservative frontpage founded by ex-military!
This gives new meaning to the expression “narrow escape”:
H/t Auntie Lulu
Better than Drudge Report. Check out Whatfinger News, the Internet’s conservative frontpage founded by ex-military!
Earlier today, Senate Majority Leader Mitch McConnell (R-Kentucky) said President Donald Trump will sign Congress’ border security compromise, which is really a bi-partisan collusion for open borders.
The product of nearly three weeks of talks, the agreement provides almost $1.4 billion for new barriers along the boundary, which is less than the $1.6 billion for border security in a bipartisan Senate bill that Trump had spurned months ago. The $1.4 billion is enough for building just 55 miles of barricades, not the 200-plus miles President Trump seeks.
The agreement also contains other hamstrings on border security, including:
Mere minutes ago, the AP reports:
The White House confirms that President Donald Trump will sign a bill averting a potential partial government shutdown at the end of the week.
Press Secretary Sarah Sanders says Trump will also take “other executive action — including a national emergency” as he seeks to keep his border wall pledge. The bipartisan congressional legislation expected to pass Thursday includes only a fraction of the billions of dollars Trump is seeking to build a wall along the U.S.-Mexico border….
McConnell also said Trump would quickly declare a national emergency. The president has said that move would give him power to divert money from other budget projects into wall building.
McConnell also said he would support Trump’s emergency declaration. That was a turnabout for the Kentucky Republican, who like Democrats and many Republicans has until now opposed such a declaration.
An emergency declaration to shift funding from other federal priorities to the border is expected to face swift legal challenge.
Better than Drudge Report. Check out Whatfinger News, the Internet’s conservative frontpage founded by ex-military!
And, lastly . . . .
Zechariah 14 is the 14th and the last chapter of the Book of Zechariah in the Old Testament. This book contains the prophecies spoken by the prophet Zechariah, whose prophecies began in the second year of Darius, king of Persia (520 BC).
Coincidentally, his feast day is today, February 8, in the Eastern Orthodox liturgical calendar.
This is the apocalyptic prophecy in Zechariah 14:1-9:
A day of the Lord is coming….
Then the Lord will go out and fight against those nations, as he fights on a day of battle. On that day his feet will stand on the Mount of Olives, east of Jerusalem, and the Mount of Olives will be split in two from east to west, forming a great valley, with half of the mountain moving north and half moving south…. Then the Lord my God will come, and all the holy ones with him.
On that day there will be neither sunlight nor cold, frosty darkness. It will be a unique day—a day known only to the Lord—with no distinction between day and night. When evening comes, there will be light….
The Lord will be king over the whole earth. On that day there will be one Lord, and his name the only name.
What the prophet Zechariah described is the end of all things, when our Lord will come for a second and last time.
“On that day his feet will stand on the Mount of Olives, east of Jerusalem, and the Mount of Olives will be split in two from east to west“
So it’s most fascinating that geologists have discovered an earthquake fault line running east to west right through the Mount of Olives in the heart of Jerusalem.
From “The Geography of the Mount of Olives” by Sefi Ben Yosef:
The Mount of Olives is a long and narrow mountain that stretches along the eastern edge of Jerusalem in a general north-south direction. Its summit lies in the center of the village of Abu Tor, at an altitude of about 820 meters above sea level, and approximately 100 meters above the Old City of Jerusalem….
The fault line from west to east, in the southern portion of the Mount of Olives, has elevated the mountain northward and exposed layers of limestone and dolomite from the Cenomanian-Turanian Period in the western section of the mountain, the same section that faces the Judean anticline.
Now, how could Zechariah, in 520 BC, know that an earthquake fault line runs east to west under the Mount of Olives?
According to Grace thru faith and several other websites, in 1964, when King Hussein of Jordan had the Intercontinental Hotel built on top of the Mount of Olives, engineers discovered the fault line running through the original construction site, which was directly East of the Temple Mount. They relocated the site to the south, desecrating hundreds of Jewish graves in the process, and built the hotel there. Today it’s called the Seven Arches Hotel.
The discovery of the earthquake fault line under the Mount of Olives leads Callum Hoare to write in the UK Express, Feb 7, 2019:
A Biblical prophecy could be fulfilled after geologists discovered a sign along a famous mountain range described in the Bible as being integral to the story of Jesus Christ’s second coming.
Mount Olivet, also known as the Mount of Olives, is a rock formation located east of Jerusalem’s Old City. It got its name from the olive groves that once covered its slopes and is popular among Christians for apparently playing a key part in several of Jesus’ life events. However, it may also hold a clue to his second coming, a strange find suggests.
See also these other confluences of science and Christianity, and of science confirming Biblical accounts:
It was too good to be true.
Three days ago, I posted the news from Jerusalem Post that a team of Israeli scientists said they “might have found the first complete cure for cancer”.
Dan Aridor, the chairman of the bio-company that developed the cure, Accelerated Evolution Biotechnologies Ltd. (AEBi), trumpets that their cure will be offered in a year, and that the cure “will be effective from day one,” “will have no or minimal side-effects,” and “at a much lower cost” than most other cancer treatments on the market.
AEBi’s claim was widely broadcast and celebrated.
The usually-sensible Daily Wire even politicized the alleged cancer cure with this anti-antiSemitic headline: “Still Want To Boycott Israel? Israeli Scientists Find Cure For Cancer, Report Says“.
I was somewhat skeptical of AEBi’s claim because no human trials have been conducted, the discovery has not been vetted and published in peer-reviewed scientific journals, nor has it be replicated. Replicability is one of the defining criteria of science. AEBi had conducted only in-vitro (test-tube) trials and one rat experiment.
The skepticism is shared by cancer experts.
From Newsweek, Jan. 30, 2019:
As news stories hailing the discovery spread online, other cancer experts urged the public to approach the report with caution.
Dr. Darren Saunders, a cancer biologist at the University of New South Wales, Australia, tweeted the researchers were “selling unicorns.”
Professor Lawrence Young, director of the Warwick Cancer Research Centre at the University of Warwick, U.K., told Newsweek he was concerned the team had not appeared to publish their data in a peer-reviewed journal, and that no clinical trials had been performed. Such trials are the first step outside of the laboratory in drug development.
Julia Frater, senior cancer information nurse at the charity Cancer Research UK, told Newsweek: “Unsubstantiated claims that there will be a cure for all cancers in a year are irresponsible and can be misleading for patients. This oversimplifies the fact that cancer is more than 200 different diseases, which behave differently and pose different treatment challenges. This is why finding a single cure for all cancers is unlikely.”
Meanwhile, Professor Chris Bunce, who specializes in translational cancer biology at the University of Birmingham, U.K., told Newsweek that widely used treatments such as chemotherapy were previously regarded as “radical” and said the “technology being talked about here may be another step in that journey. But based on the information available the claim that it will provide a ‘complete cure for cancer’ is unfounded.”
Professor Justin Stebbing, an expert in cancer medicine and oncology at Imperial College London, U.K., told Newsweek that research at the Weizmann “is some of the best in the world.” But he said he is yet to see any success with peptides treating any cancers. “It isn’t helpful to build up false hope, or talk of universal cancer cures when advances in knowledge are often made in small steps not giant leaps,” he said.
Bunce explained why creating cancer drugs is so difficult. “On one hand cancer cells are not the big scary monsters that the general public believes them to be. More than 99.9 percent of the molecular processes within them are the same as the normal cells they originate from. So finding drugs that only target cancer cells is like finding needles in haystacks. The second problem is that within a given cancer there is complex variation and structure. There are cancer stem cells, and there are cancer subclones with different arrays of mutations and different levels of resistance to any given therapy. Painful lessons have been learned trying to exploit drugs that do not target founding mutations.”
Even many hopeful laboratory findings cannot be translated into actual therapies that are successful, he said.
Bunce argued it is “unethical” to make overly optimistic claims that raise people’s hopes and “discredit those of us who are working really hard to find better treatments.”
Let’s hope this new cancer cure won’t turn out to be another cold fusion pipedream.
According to the International Agency for Research, cancer is the second leading cause of death, second only to cardiovascular disease, accountable for every sixth death in the world. Each year, an estimated 18.1 million new cancer cases are diagnosed worldwide.
Maayan Jaffe-Hoffman reports the earth-shaking news for the Jerusalem Post, January 28, 2019, that a team of Israeli scientists believe they “might have found the first complete cure for cancer”.
The company, Accelerated Evolution Biotechnologies Ltd. (AEBi), is developing the new cancer treatment. Founded by Dr. Ilan Morad in 2000 in Weizmann Science Park in Ness Ziona, Israel, AEBi developed the SoAP platform, a breakthrough technology that allows AEBi to develop drugs to many illnesses, among them cancer.
AEBi chairman of the board Dan Aridor, said:
“We believe we will offer in a year’s time a complete cure for cancer. Our cancer cure will be effective from day one, will last a duration of a few weeks and will have no or minimal side-effects at a much lower cost than most other treatments on the market. Our solution will be both generic and personal.”
MuTaTo (multi-target toxin) — is essentially on the scale of a cancer antibiotic – a disruption technology of the highest order.says his company’s cancer treatment — the
The potentially game-changing anti-cancer drug is based on SoAP technology, which belongs to the phage display group of technologies. It involves the introduction of DNA coding for a protein, such as an antibody, into a bacteriophage – a virus that infects bacteria. That protein is then displayed on the surface of the phage. Researchers can use these protein-displaying phages to screen for interactions with other proteins, DNA sequences and small molecules.
In 2018, a team of scientists won the Nobel Prize for their work on phage display in the directed evolution of new proteins – in particular, for the production of antibody therapeutics. AEBi is doing something similar but with peptides — compounds of two or more amino acids linked in a chain.
Morad explains that peptides have several advantages over antibodies, including being smaller, cheaper, and easier to produce and regulate.
Morad said that when his company, AEBi, was first founded, “We were doing what everyone else was doing, trying to discover individual novel peptides for specific cancers.” Shortly thereafter, Morad and his colleague, Dr. Hanan Itzhaki, decided they wanted to do something bigger. They wanted to identify why other cancer-killing drugs and treatments don’t work or eventually fail. Then they found a way to counter that effect.
As explained by Morad, this is how AEBi’s multi-target toxin (MuTaTo) is superior to other cancer-fighting drugs/methods:
(1) Most anti-cancer drugs attack a specific target on or in the cancer cell. But mutations in the targets or in their physiological pathways could make the targets not relevant to the cancer nature of the cell, and hence render ineffective the drug attacking the cancer cell. AEBi’s MuTaTo uses a combination of several cancer-targeting peptides for each cancer cell at the same time, combined with a strong peptide toxin that specifically kills cancer cells. Morad explains that by using at least three targeting peptides on the same structure with a strong toxin, “the treatment will not be affected by mutations; cancer cells can mutate in such a way that targeted receptors are dropped by the cancer. The probability of having multiple mutations that would modify all targeted receptors simultaneously decreases dramatically with the number of targets used. Instead of attacking receptors one at a time, we attack receptors three at a time – not even cancer can mutate three receptors at the same time.”
(2) When targeted by drugs, many cancer cells activate detoxification mechanisms by pumping out the drugs or modifying them to be non-functional. But AEBi’s MuTaTo is so strong that “it has a high probability of killing the cancer cell before detoxification occurs, which is what he is banking on”.
(3) Many cytotoxic anticancer treatments aim at fast-growing cells, but cancer stem cells are not fast growing, and so escape these treatments. Worse still, when the treatment is over, the cells can generate cancer again, this time, drug resistant. Morad explains that because cancer cells are born out of mutations that occur in cancer stem cells, most of the overexpressed proteins which are targeted on the cancer cell exist in the cancer stem cells. MuTaTo’s multiple-target attack ensures that they will be destroyed as well.
(4) Some cancer tumors erect shields which create access problems to large molecules, such as antibodies. But MuTaTo, with very small peptides (12 amino acids long), acts like an octopus or a piece of spaghetti and can sneak into places where other large molecules cannot reach. Morad explains, “This should make the whole molecule non-immunogenic in most cases and would enable repeated administration of the drug.”
(5) Most cancer treatments have sickening side-effects from the treatments interacting with the wrong or additional targets, or the correct targets but on non-cancerous cells. Morad said MuTaTo would “dramatically” decrease those side-effects because it specifically targets cancer cells and, “in most cases,” avoids targeting non-cancer cells that have a protein in common with the cancer cells.
Morad compares MuTaTo to the triple drug cocktail that has helped change AIDS from being an automatic death sentence to a chronic – but often manageable – disease, so that people with AIDS today are HIV carriers, “but they are not sick anymore::
“We used to give AIDS patients several drugs, but we would administer them one at a time. During the course of treatment, the virus mutated, and the AIDS started attacking again. Only when patients started using a cocktail, were they able to stop the disease.”
Unlike the triple-drug AIDS cocktail that patients must take throughout their lives, MuTaTo would kill the cancer cells outright. This means the treatment could likely end after only a few weeks.
The MuTaTo cancer treatment will eventually be personalized. Each patient will provide a piece of his biopsy to the lab, which would then analyze it to know which receptors are “overexpressed”. The individual would then be administered exactly the molecule cocktail needed to cure his disease.
Morad said that AEBi has concluded several in-vitro trials and its first exploratory mice experiment, in which MuTaTo inhibited human cancer cell growth with no effect at all on healthy mice cells. AEBi chairman Aridor said “Our results are consistent and repeatable.”
AEBi is “on the cusp” of beginning a round of clinical, i.e., human, trials which could be completed within a few years, after which treatment could be available in specific cases.
In other words, AEBi’s claim to have discovered the first complete cure for cancer is somewhat premature. No human trials have been conducted; only in-vitro (test-tube) trials and one rat experiment have been made. The scientists’ discovery has not been vetted and published by peer-reviewed journals, nor has it been replicated by other scientists, replicability being a necessary condition for scientific truth.
Update: see “Cancer experts doubt Israeli claim of cancer cure“.
An exhibition at the Haifa Museum of Art in Israel displays artworks that insult Jesus Christ, but not the Islamic and Judaic religions.
The museum describes the “Sacred Goods” exhibition, curated by Shaked Shamir, which began on August 4 last year and ends today, as follows:
This exhibition focuses on the responses of contemporary artists to issues of religion and faith in the contemporary global reality, which is dominated by the consumer culture. In recent decades, various cultures and places around the world have witnessed a surprising religious revival. Theorist Boris Groys argues that in a world that has renounced the grand secular ideologies, the return to religion fulfills the need for meaning. Contemporary religions offer answers to the ills of the modern world and the sense of emptiness that pervades this era of extreme individualism and aggressive capitalism…. Consumer culture dictates a superficial interest in religious products and techniques, while ignoring the philosophical and ethical meanings of religion…. In the contemporary context, the artists participating in the exhibition employ religious symbols to criticize the encroachment of the consumer culture on our lives in general, and on the religious sphere in particular. The artists also criticize the way religions use consumer values and practices in order to prosper in the contemporary reality.
The participating artists are identified as Elodie Abergel, Ido Abramsohn, Gabi Ben Avraham, Magnus Gjoen, Vania Heymann, Jani Leinonen, Tony Leone, Ariane Littman, Esther Naor, Karam Natour, Pool & Marianela, and Nick Stern.
The exhibition includes these artworks and images that blaspheme God the Father, Jesus Christ and insults Christianity:
Our Lord Jesus Christ as a Ken doll:
Mocking His Crucifixion:
Mocking His Resurrection:
But no mockery of the Ark of the Covenant that’s celebrated in Judaism, or any other Judaic symbol or figure, nor of Islam:
In addition to insulting Jesus, the art exhibition trashes religion in general, while glorifying globalization:
In a reality wherein globalization aspires for cultural unification, religion offers its followers the illusion of a return to their roots and to distinctive local traditions.
Christian leaders in Israel have singled out Finnish artist Jani Leinonen‘s McJesus sculpture of a crucified Ronald McDonald, while ignoring the other offensive exhibits.
For his part, Leinonen said that last September, he had requested his McJesus sculpture be removed from the museum’s Sacred Goods exhibition, to no avail, and that McJesus is on display against his wishes.
In early January 2019, some four months after the opening of the “Sacred Goods” exhibition, Israel’s culture minister Miri Regev sent museum director Nissim Tal a letter week demanding McJesus’s removal, writing that: “Disrespect of religious symbols sacred to many worshippers in the world as an act of artistic protest is illegitimate and cannot serve as art at a cultural institution supported by state funds.” But the museum refused to remove the sculpture.
On January 14, 2019, hundreds of Christians protested outside the Haifa Museum of Art against McJesus. Violent clashes broke out between Christian protesters who tried to storm their way into the museum and the police, after a molotov cocktail was thrown at the museum the day before.
One of the protesters complained that the Israeli government was slow to respond because McJesus mocks Christianity and not Judaism: “If they put up [a sculpture of] Hitler with a Torah scroll they would immediately respond.” (The Art Newspaper)
Ariel Gold, National Co-Director for Code Pink, was on the Ingraham Angle trying to defend Women’s March founder and anti-Semite Linda Sarsour. Michelle Malkin takes her on the hilarity ensues.
Gold is a useful idiot who has a mental disorder called liberalism.
Begin video at 25:37 mark.
Founded in 1986, the European Jewish Congress (EJC) is an umbrella organization of 42 national Jewish communities in Europe, representing more than 2.5 million European Jews. Affiliated to the World Jewish Congress, the EJC is one of the most influential international public associations. It works with national governments, European Union institutions and the Council of Europe. Based in Paris, the EJC has offices in Brussels, Strasbourg, Berlin and Budapest.
The Jerusalem Post reports that on November 21, 2018, the EJC convened a high level conference in Vienna, Austria, on “Europe beyond antisemitism and anti-Zionism – securing Jewish life in Europe”.
The conference was arranged by the Federal Chancellery of Austria led by Austrian Chancellor Sebastian Kurz who, in his opening address, said “Antisemitism and anti-Zionism are getting blurred, but they are two sides of the same coin.”
Israeli Prime Minister Benjamin Netanyahu gave a recorded video speech at the conference, in which he said that antisemitism was resurgent again “throughout the world,” and that a new antisemitism has arisen which attempts “to demonize the Jewish state and prevent the Jewish people the right to self-determination in the homeland of our forefathers, the Land of Israel. Netanyahu said that “The Holocaust did not begin in the gas chambers of Auschwitz. The Holocaust began with the spread of hate speech, the burning of books and the smashing of shop windows.”
EJC president Dr. Moshe Kantor said at the conference:
“Today, on European streets, people are being killed again simply for being Jewish. Jewish communities in Europe are increasingly concerned about their security and pessimistic about their future. Europe doesn’t have a monopoly on antisemitism anymore. No Jewish community anywhere in the world, however strong and well organized, is now immune from Jew hatred. Fighting antisemitism deserves much more than simple statements of good will – we need concrete policies and reinforced legislation.”
To that end, the conference produced a Catalogue of Policies to Combat Antisemitism — detailed proposals and recommendations for combating antisemitism in Europe, drawn up by the EJC with the assistance of academics from universities in Vienna, Tel Aviv and New York. (Daily Mail names Israeli historian Dina Porat and New York University professor Lawrence H. Schiffman as among the academics.)
Chancellor Kurz said he intends to bring the document before the European Council, the body comprising the 28 EU member heads of state that determines policy direction, at its next summit in December. Raising the issue at the European Council would be prelude to the adoption of the recommendations by the EU and Europe’s national governments.
On its website, the European Jewish Congress identifies the following recommendations of the Catalogue of Policies to Combat Antisemitism:
Curiously, left out of the above recommendations is the call for new editions of the Bible and Koran to carry warning messages about anti-Semitic passages.
James Wood reports for Daily Mail, Nov. 23, 2018, that the recommendation is in the EJC’s conference document, An End to Antisemitism! A Catalogue of Policies to Combat Antisemitism, in a chapter entitled “Recommendations regarding Religious Groups and Institutions”. The document reads:
Translations of the New Testament, the Qur’an and other Christian or Muslim literatures need marginal glosses, and introductions that emphasize continuity with Jewish heritage of both Christianity and Islam and warn readers about antisemitic passages in them. While some efforts have been made in this direction in the case of Christianity, these efforts need to be extended and made consistent in both religions.
The Catalogue of Policies to Combat Antisemitism also calls for:
The Catalogue‘s justification for these changes is because divine messages are always communicated through human beings and therefore subject to error. It reads:
God’s revelation is thus marred by human fallibility. Beginning with the New Testament, divine revelation expresses itself in Christian holy texts that also express a form of hatred. The manifestations of this hatred resulted in a tradition of antisemitism that gave moral legitimacy to crimes against the Jewish people, the epitome of which is the Shoah.
Several themes in the New Testament have come under fire for being anti-Semitic. These include blaming Jews for the death of Jesus, and negative remarks about the stubborn nature of the Jewish people and their disloyalty to God.
So what is the IHRA working definition of antisemitism?
On May 26, 2016, the International Holocaust Remembrance Alliance (IHRA) — of which the United States is a member — adopted the following the “non-legally binding working definition of antisemitism“, which is used by the U.S. State Department:
Antisemitism is a certain perception of Jews, which may be expressed as hatred toward Jews. Rhetorical and physical manifestations of antisemitism are directed toward Jewish or non-Jewish individuals and/or their property, toward Jewish community institutions and religious facilities.
Alas, the working definition does not define what “hatred toward Jews” means, but that meaning can be gleaned from what the IHRA considers to be contemporary examples of antisemitism, including:
What the IHRA, European Jewish Congress and its Catalogue of Policies to Combat Antisemitism conveniently omit is that the Talmud, which supercedes the Torah (Old Testament) in religious authority for Jews, is rabidly anti-Christian.
Written in Hebrew between the third and sixth centuries, the Talmud is a collection of 63 books that together codify the oral law that Jewish rabbis claim was handed down from Moses. Jesus, in Matthew 15, however condemns that oral law when he said: “By the traditions of your elders you make void the Word of God.”
English translations of the Talmud have been watered down so as to conceal from the Gentiles the “satanic verses” contained in the original Hebrew. Those “satanic verses” can be classified into three categories:
Israel is the largest cumulative recipient of U.S. foreign assistance since World War II.
To date, the United States has provided Israel $134.7 billion (current, or non-inflation-adjusted, dollars) in bilateral assistance and missile defense funding. Almost all U.S. bilateral aid to Israel is in the form of military assistance, although in the past Israel also received significant economic assistance. (Source: Congressional Research Service Report to Congress, February 26, 2018)
Callum Paton reports for Newsweek that on August 9, 2017, the Israeli Defense Forces (IDF) revealed construction details of a new $800 million underground wall to run along Israel’s 40-mile border with Gaza and extending into the Mediterranean.
Israel already is protected by a 143-mile border fence, touted by Sen. Ron Johnson (R-WI) for drastically reducing illegal immigration along its southern border:
“Israel … had a real problem with illegal immigrants coming in from the southern border, about 16,000 in one year. In two years, they constructed 143-mile fence, about $2.9 million per mile, and it cut that illegal immigration rate from about 16,000 to I think 18. Cut it by 99 percent.”
The new $800 million wall is to protect Israel from the threat of attack tunnels dug by Hamas, the Islamist militant group that has controlled Gaza since 2007, and to stop Hamas fighters from swimming ashore.
The wall, 19-ft. high and 131 feet underground, will be constructed mainly from concrete, reinforced with iron bars and pipes and covered in sensors. Work on the wall began in October 2017 and is expected to take two years to complete.
Meanwhile, Paul Dijks reports for Voice of Europe that on Nov. 20, 2018, Prime Minister Benjamin Netanyahu cited Israel’s need to protect its borders as the reason why Israel will not be signing the United Nations’ global migration pact set to be formally approved on December 12 in Marrakech, Morocco.
Netanyahu said in a statement:
I instructed the Foreign Ministry to announce that Israel won’t participate [in the Marrakech gathering]and won’t sign the migration pact. We have a duty to guard against illegal infiltrators. [Jewish Nation-State Law requires the government] to stand up for a clear migration policy that protects our borders from illegal infiltrators.
Seven countries have withdrawn from the UN global migration pact over concerns about national sovereignty: Australia, Austria, Bulgaria, the Czech Republic, Hungary, Poland, and the United States.
On December 2, 2017, the Trump administration announced that the U.S. Mission to the United Nations had informed the UN Secretary-General that the United States is ending its participation in the Global Compact on Migration because the compact is “inconsistent” with U.S. policies:
The New York Declaration contains numerous provisions that are inconsistent with US immigration and refugee policies and the Trump Administration’s immigration principles. As a result, President (Donald) Trump determined that the United States would end its participation in the Compact process that aims to reach international consensus at the UN in 2018.
Curiously, Jews outside of Israel are rabidly pro-migration and anti-border wall. See: